Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
156.57x
As of Sep 29, 2025
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Sep 29, 2025 | 156.57x |
| Sep 26, 2025 | 149.27x |
| Sep 25, 2025 | 133.85x |
| Sep 24, 2025 | 137.10x |
| Sep 23, 2025 | 126.55x |
| Sep 22, 2025 | 131.42x |
| Sep 19, 2025 | 124.93x |
| Sep 18, 2025 | 120.87x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison